Synplogen collaborates with Ginkgo Bioworks

Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan

Synplogen Co., a synthetic biology startup spun out of Kobe University’s Graduate School of Science, Technology and Innovation that provides custom DNA synthesis and Gene Therapy Biofoundry services, and Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, today announced that they have entered into a non-binding Memorandum of Understanding (“MOU”). Together, Synplogen […]